VANCOUVER, British Columbia, Nov. 16, 2017 (GLOBE NEWSWIRE) — Harvest One Cannabis Inc. (TSXV: HVST) (“Harvest One”) through its wholly owned Swiss Subsidiary Satipharm AG (“Satipharm”) is pleased to advise
Growth Capitalist (https://growthcapitalist.com/2017/11/phase-1-clinical-trial-results-using-satipharm-capsules-published-in-international-medical-journal/)
VANCOUVER, British Columbia, Nov. 16, 2017 (GLOBE NEWSWIRE) — Harvest One Cannabis Inc. (TSXV: HVST) (“Harvest One”) through its wholly owned Swiss Subsidiary Satipharm AG (“Satipharm”) is pleased to advise